Citation
81 FR 22283
Multiple canonical documents share this first-page citation.
- Product-Specific Bioequivalence Recommendations; Draft and Revised Draft Guidances for Industry; Availability Friday, April 15, 2016 81 FR 22283
- Product-Specific Bioequivalence Recommendations; Draft and Revised Draft Guidances for Industry; Availability Friday, April 15, 2016 81 FR 22283
- Data Integrity and Compliance With Current Good Manufacturing Practice; Draft Guidance for Industry; Availability Friday, April 15, 2016 81 FR 22281
- Data Integrity and Compliance With Current Good Manufacturing Practice; Draft Guidance for Industry; Availability Friday, April 15, 2016 81 FR 22281
- Xanodyne Pharmaceuticals, Inc., et al.; Withdrawal of Approval of 8 New Drug Applications and 46 Abbreviated New Drug Applications for Propoxyphene Products; Correction Friday, April 15, 2016 81 FR 22283
- Xanodyne Pharmaceuticals, Inc., et al.; Withdrawal of Approval of 8 New Drug Applications and 46 Abbreviated New Drug Applications for Propoxyphene Products; Correction Friday, April 15, 2016 81 FR 22283
- Federal Register Vol. 81, No.73, April 15, 2016 Friday, April 15, 2016 81 FR 22283